Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Neurotrophic Keratitis: Differential Diagnosis, Treatment Options, and Case Discussions

By: Marjan Farid, MD, and Francis S. Mah, MD

Webinar Credits: 1.0

This CME webinar will highlight the various ways in which neurotrophic keratitis can present and will also include practical information on current and investigative treatment options. The program hosts will discuss challenging cases.

Expiration Date: Sunday, February 28, 2021
Release Date: February 25, 2020

Learning Objectives

At the completion of this educational activity, the participating ophthalmologist will be better able to:

  • Describe the stages of neurotrophic keratitis and how to differentiate it from similar diseases.
  • Recognize the various potential causes of neurotrophic keratitis.
  • Understand the mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis.
  • Identify the relationships between disease characteristics, drugs, treatment frequency, visual, and anatomic outcomes.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grantor Statement
Supported through an educational grant from Dompé.

Faculty and Disclosures

DISCLOSURE POLICY

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Faculty

Marjan Farid, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Biotissue, CorneaGen, and Novartis. Grant/Research Support: Allergan, Dompé, and Johnson & Johnson Vision.

Francis S. Mah, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Dompé.

Editorial Support

Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests.

Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests.

Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.

Pretest

  • 1 Not at all confident2 Not very confident3 Neutral4 Confident5 Very confident

Video Resources

Next

Test

Instructions

Step 1 of 2

50%
  • Not at all confidentNot very confidentNeutralConfidentVery confident
  • AgreeNeutralDisagree
    Describe the stages of neurotrophic keratitis, and how to differentiate it from similar diseases.
    Recognize the various potential causes of neurotrophic keratitis.
    Understand mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis.
    Identify the relationships between disease characteristics, drug, treatment frequency, visual and anatomic outcomes.
Back